A field guide to BPC-157The criteria
PRODUCT / CARE / COMMITMENT
Open the provider file

Research explained

BPC-157 in a colon-to-skin fistula study

Background mentions of clinical development do not turn the rat experiment into a human trial.

On this page

Read the experiment

The finding and its boundary

The authors reported accelerated closure-related and functional findings in the model. Background mentions of clinical development do not turn the rat experiment into a human trial.

Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system.

Experiment
Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
Study system
Rats with defined surgical colon and skin defects
Measured outcome
Leakage, pressure tolerance, tissue healing and function
Reported result
The authors reported accelerated closure-related and functional findings in the model.
What this cannot establish
Background mentions of clinical development do not turn the rat experiment into a human trial.
Open the primary paper

What was actually tested

Rats with defined surgical colon and skin defects. The investigators measured leakage, pressure tolerance, tissue healing and function. The authors reported accelerated closure-related and functional findings in the model.

The detail that changes the takeaway

A publication can discuss earlier clinical programs in its introduction while presenting only animal data itself. Keep the actual participants in the summary. The model's pressure-tolerance measurement is more specific than the general statement that a fistula healed and should be interpreted on its own terms.

How far the result travels

Background mentions of clinical development do not turn the rat experiment into a human trial.

A useful comparison

BPC-157 and an airway-to-skin fistula in rats examines airway and skin defects, respiratory signs, leakage and tissue measures. Here, the measured endpoint was leakage, pressure tolerance, tissue healing and function. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with the BPC-157 and fistula healing: closure and tissue strength are separate endpoints appraisal.

References & product documents

The evidence and service information used here.

  1. BPC-157 in a colon-to-skin fistula study — original indexed research

Next in the field guide

The provider file
  1. 01

    BPC-157 and fistula healing: closure and tissue strength are separate endpoints

    A rat experiment linked stomach and skin defects. It does not establish treatment for a patient’s fistula or justify delaying specialist care.

  2. 02

    BPC-157 and an airway-to-skin fistula in rats

    This does not establish nonsurgical management of a human airway fistula.

  3. 03

    BPC-157 and an established fistula in rats: delayed treatment is still preclinical

    A 2021 experiment tested a surgically created urinary fistula after it had formed. It did not compare human surgical and peptide treatment strategies.

Before you leave

One more option to compare.

Another provider review

We may earn a commission from qualifying provider referrals. Affiliate placements are labeled Partner. How we are funded

Continue to your choiceRead another review